EGF and breast carcinoma: Dimethyl melaleucate and three structurally related PTs, ursolic acid, 18α-glycyrrhetinic acid, and carbenoxolone suppress EGF mediated breast cancer proliferation through sustained inhibition of EGFR and its downstream effectors STAT3 and cyclin D1 in breast cancer lines [28].